In 2006, A keratinocyte proliferation assay was used to assess the effect of treatment with cannabinoids.
BACKGROUND: non-CB1/CB2 mechanism have a potential therapeutic value in the treatment of psoriasis.
You can read the full article here => https://www.ncbi.nlm.nih.gov/pubmed/17157480